Evidence map›Paper›PMID 32965025›Full record

ArticleVox sanguinis2021

Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression.

Fumiichiro Yamamoto, Miyako Yamamoto, Eduardo Muñiz-Diaz

Open access · bronzeAbstract readComment
In one paragraph

Article in Vox sanguinis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. The rs8176740Biomolecules · 2022
    Article
  8. Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2022
    Article
  9. Observational
  10. Review
  11. The association of ABO blood group with the asymptomatic COVID-19 cases in India.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. ABO phenotype and SARS-CoV-2 infection: Is there any correlation?Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Fumiichiro YamamotoLaboratory of Immunohematology and Glycobiology, Josep Carreras Leukaemia Research Institute, Badalona, Spain.ORCID 0000-0001-9690-7034
Miyako YamamotoLaboratory of Immunohematology and Glycobiology, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
Eduardo Muñiz-DiazDepartment of Immunohematology, Banc de Sang i Teixits - BST, Barcelona, Spain.
Josep Carreras Leukaemia Research Institute · ESBanc de Sang i Teixits · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19PneumoniaABO Blood-Group SystemHumansPolymorphism, GeneticSARS-CoV-2ABO Blood-Group System

Identifiers

PMID32965025
PMCPMC7537232
OpenAlexW3087042917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.